-
Article
Open AccessThe Geras Solutions Cognitive Test for Assessing Cognitive Impairment: Normative Data from a Population-Based Cohort
There is a need for the development of accurate, accessible and efficient screening instruments, focused on early-stage detection of neurocognitive disorders. The Geras Solutions cognitive test (GSCT) has show...
-
Article
Open AccessDigital Screening for Cognitive Impairment — A Proof of Concept Study
Due to an ageing demographic and rapid increase of cognitive impairment and dementia, combined with potential disease-modifying drugs and other interventions in the pipeline, there is a need for the developmen...
-
Article
Open AccessAre neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
The underlying disease mechanism of neuropsychiatric symptoms (NPS) in dementia remains unclear. Cerebrospinal fluid (CSF) biomarkers for synaptic and axonal degeneration may provide novel neuropathological in...
